Patents
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
02/2005
02/09/2005CN1578659A Modulators of peroxisome proliferator activated receptors (ppar)
02/09/2005CN1188420C Fungicides for preventing and curing full rot disease of plants
02/09/2005CN1188419C Fungicides for control of full-rot disease of plants
02/08/2005US6852882 N-(2-(N-formyl-N-hydroxyamino)ethyl)arylamides with bacterial polypeptide deformylase inhibiting activity
02/08/2005US6852830 Polythiophenes formed form monomers such as (2,3-dihydro-thieno(3,4-b)(1,4)dioxin-2-yl-methoxy)-acetic acid, for use as coatings, printable pastes or electroconductive layers
02/08/2005US6852751 Difluorobutyric acid metalloprotease inhibitors
02/08/2005US6852747 Resorcinol derivatives
02/08/2005US6852711 HIV protease inhibitors
02/08/2005US6852458 Electrophotographic photoreceptor, and electrophotographic apparatus using the same
02/08/2005US6852350 For flavouring of foodstuffs
02/03/2005WO2005009986A1 One-pot preparation of s-(guanidino-4-yl-methyl)-isothiourea dihydrochoride
02/03/2005WO2005009947A2 Aryl heteroaromatic products, compositions comprising the same and use thereof
02/03/2005WO2005009941A1 Indane derivates as muscarinic receptor agonists
02/03/2005WO2005009940A1 Novel aminobenzophenone compounds
02/03/2005WO2005009104A2 Benzoic and phenyl acetic acid derivatives as hnf-4 modulators
02/03/2005WO2004094384A3 (hetero) arylamide 2-hydroxy-3-diaminoalkanes for use in the treatment of alzheimer’s disease
02/03/2005WO2004074242A3 Halogenated oxime derivatives and the use thereof as latent acids
02/03/2005US20050027009 New derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
02/03/2005US20050026926 N, N'-disubstituted piperazine compounds and their use as analgesics
02/03/2005US20050026908 Can bind to Prostaglandin E2 receptors, especially, EP3 receptor and/or EP4 receptor and show antagonizing activity, and may be useful for prevention and/or treatment of disease, for example, pain, allergy, Alzheimer's disease, cancer
02/03/2005US20050026785 Novel phenyl-propargylether derivatives
02/03/2005US20050025997 Luminescent layer between electrodes
02/03/2005US20050023507 pi-electron donor group bonded to a pi-electron conjugated bridge group bonded to a mono- or dicyanodihydrofuran acceptor; large hyperpolarizability, dipole moment, and electrooptic coefficients; electrooptics
02/03/2005CA2533494A1 Aryl heteroaromatic products, compositions comprising the same and use thereof
02/03/2005CA2530302A1 Novel aminobenzophenone compounds
02/03/2005CA2529036A1 Indane derivates as muscarinic receptor agonists
02/02/2005EP1501821A1 New organic compounds for electroluminescence and organic electroluminescent devices using the same
02/02/2005EP1501820A1 Methylthiophene carboxanilides
02/02/2005EP1501805A1 Substituted pyrazolyl compounds for the treatment of inflammation
02/02/2005EP1501800A1 Bombesin antagonists
02/02/2005EP1501508A1 Inhibitors of histone deacetylase
02/02/2005EP1330233B1 Method of treating stroke
02/02/2005EP1286955B1 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides
02/02/2005CN1575327A Europium-ammonium tetra chelates
02/02/2005CN1575286A Thiophene-amd thiazolesulfonamides as antineoplastic agents
02/02/2005CN1575283A Piperazine derivatives with CCRI receptor antagonist activity
02/02/2005CN1575279A Substituted thioacetamides
02/02/2005CN1575275A Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives
02/02/2005CN1575273A 3, 4-di-substituted cyclobutene-1, 2-diones as CXC-chemokine receptor antagonists
02/01/2005US6849744 3-(substituted phenyl),4-substituted-5H-1,2-oxathiole 2-oxide or 2,2-dioxide compounds useful as agricultural fungicides, insecticides, herbicides
02/01/2005US6849739 N-heterocyclic derivatives as NOS inhibitors
02/01/2005US6849738 Use as Gonadotropin releasing hormone (GnRH) antagonistic activity, and chemical intermediates; 5-(tert-aminomethyl)-1-(arylmethyl)-6-(4-(ureido)phenyl)-3-hydrocarbyl -thieno(2,3-d)pyrimidine-2,4-dione for example
02/01/2005US6849733 Compounds containing amidated guanidine derivative type functional group of structure N-C(=N)-N-CO-N-C=N or N-C(=N)-N-CO-N
02/01/2005US6849660 Antimicrobial biaryl compounds
02/01/2005US6849635 Sulfonamides
02/01/2005US6849617 Administering Tissue factor pathway inhibitors for prophylaxis of thrombosis and cardiovascular disorders; anticoagulants
02/01/2005US6849384 Photoacid generators, photoresist compositions containing the same and pattering method with the use of the compositions
02/01/2005US6849202 Compound having phenylacetylene structure, liquid crystal composition, polymer, optically anisotropic product, optical or liquid crystal element, dibenzothiophene compound, intermediate, and process for producing the same
02/01/2005US6849097 I.e., N-(thiophen-2 or-3-ylmethyl)-, N-(furan-3-ylmethyl)-, N-(1H-imidazol-2-ylmethyl)- and N-(pyrrol-2-ylmethyl)-p-phenylenediamines; developers for hair dyes
01/2005
01/27/2005WO2005007635A2 Combretastatin derivatives with cytotoxic action
01/27/2005WO2005007621A2 Ubiquitin ligase inhibitors
01/27/2005WO2004108673A3 Inhibitors of papilloma virus
01/27/2005US20050020849 via non-racemic cinchona-alkaloid-type catalyst (quinidine) for addition of nucleophile
01/27/2005US20050020837 N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists
01/27/2005US20050020684 Modulators of peroxisome proliferator activated receptors
01/27/2005US20050020667 Compounds and therapies for the prevention of vascular and non-vascular pathologies
01/27/2005US20050020665 For example, N-hydroxy-N-(1-benzo[b]thien-2-ylethyl) acetamide,1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxy urea,N-hydroxy-N-(1-benzo[b]thien-2-ylethyl)-N'-methyl urea
01/27/2005US20050020635 C7 carbamoyloxy substituted taxane compositions
01/27/2005US20050020634 Acat inhibitors; cardiovascular disorders; restenosis; Alzheimer's disease
01/27/2005US20050020602 Bone disorders; reduction concentration of parathyroid hormone in blood
01/27/2005US20050020593 Anticancer agents
01/27/2005US20050020540 Biphenylcarboxylic amide derivatives as p38-kinase inhibitors
01/27/2005US20050020481 Ion channel modulating compounds and uses thereof
01/27/2005US20050020450 Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives
01/27/2005US20050019689 Stimulus-sensitive composition, compound and pattern formation method using the stimulation-sensitive composition
01/27/2005US20050015898 Hair dyes for keratin fibers
01/27/2005CA2531389A1 Combretastatin derivatives with cytotoxic action
01/26/2005EP1500977A1 Radiation-sensitive composition, compound and pattern formation method using the radiation-sensitive composition
01/26/2005EP1500432A1 Method for preparing ruthenium-carrying alumina and method for oxidizing alcohol
01/26/2005EP1499605A2 NF-KappaB INHIBITORS
01/26/2005EP1499597A2 Compounds and methods for inducing apoptosis in proliferating cells
01/26/2005EP1499309A1 Prevention and treatment of functional somatic disorders, including stress-related disorders
01/26/2005EP1353639A4 Primary intermediates for oxidative coloration of hair
01/26/2005EP1185524B1 3-heteroarylalkyl substituted gaba analogs
01/26/2005EP0983267B1 Amidoaromatic ring sulfonamide hydroxamic acid compounds
01/26/2005CN1571667A Inhibitors of dipeptidyl peptidase ó¶
01/26/2005CN1186344C Amino acid compounds and use thereof as NEP, ACE and ECE inhibitors
01/26/2005CN1186332C New thryoid receptor ligands and process II
01/26/2005CN1186320C Thiol and sulfur-containing O-(meth)acrylate counpounds and use thereof
01/25/2005US6846954 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
01/25/2005US6846934 Photochromic diarylethene substituted with isoxazole group
01/25/2005US6846843 β-thioamino acids
01/25/2005US6846829 N-heterocyclic derivatives as NOS inhibitors
01/25/2005US6846825 Antibacterial agents
01/25/2005US6846813 For inhibiting beta-secretase enzyme activity and A beta peptide production, inhibition of beta-secretase enzyme activity halts or reduces production of A beta from APP and reduces or eliminates the formation of beta-amyloid deposits
01/20/2005WO2005006807A1 Transmitter of wireless microphone, receiver for wireless microphone, mobile information communication apparatus, and communication system for wireless microphone
01/20/2005WO2005006806A1 Wireless microphone communication system
01/20/2005WO2005005383A1 Amino alcohol compound
01/20/2005WO2005005374A1 Aspartyl protease inhibitors
01/20/2005WO2004103941A3 Aryl-carbaldehyde oxime derivatives and their use as estrogenic agents
01/20/2005US20050014941 Cyanoalkylamino derivatives as protease inhibitors
01/20/2005US20050014822 Carbonylamino-substituted acyl phenyl urea derivatives, process for their preparation and their use
01/20/2005US20050014817 Fluorothiophene derivatives, process for preparing them and pharmaceutical compositions containing them
01/20/2005US20050014816 Thiophene amino acid derivatives, process for preparing them and pharmaceutical compositions containing them
01/20/2005US20050014796 Mediators of hedgehog signaling pathways, compositions and uses related thereto
01/20/2005US20050014791 Inhibitors of papilloma virus
01/20/2005US20050014787 5-amidino-2-hydroxybenzenesulfonamide derivatives medicinal compoistions containing the same medicinal use thereof and intermediates in the production thereof
01/20/2005US20050014765 Aryl-heteroaromatic products, compositions comprising them and use
01/20/2005US20050014725 Immunosuppressant compounds and compositions
01/20/2005US20050012068 Stable solutions of organic semiconducting compounds